Indeed, a recent paper highlighted that C9-ALS patients with larger expansions had a more severe cognitive impairment, thereby supporting the emerging hypothesis that C9orf72 hexanucleotide repeats size might be a modifier of phenotype along the FTLD clinical spectrum [60]. Here, C9orf72 is linked to amyotrophic lateral sclerosis.